Acceptance of tamoxifen chemoprevention by physicians and women at risk

Cancer. 2005 Jan 1;103(1):209-10. doi: 10.1002/cncr.20744.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / prevention & control*
  • Chemoprevention
  • Decision Making
  • Female
  • Humans
  • Patient Acceptance of Health Care*
  • Physician-Patient Relations
  • Prospective Studies
  • Risk Assessment
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen